skip to search skip to navigation skip to main content

Archive: April 2017

Astellas to Acquire Ogeda SA

05th April 2017 in Mergers & Acquisitions

Acquisition expands Astellas’ late stage clinical pipeline with Fezolinetant Tokyo, Japan and Gosselies, Belgium, April 3, 2017 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Ogeda SA (CEO:Jean Combalbert, ”Ogeda”) announced today that Astellas and Ogeda shareholders have entered into a definitive agreement under which Astellas has agreed to acquire…

Read Full Post

Privacy Policy  |  Terms of Use  |  Cookies PolicyCopyright © 2019 Astellas Pharma